Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Sep;47(9):777–781. doi: 10.1136/jcp.47.9.777

Immunophenotyping in the diagnosis of acute leukaemias. General Haematology Task Force of BCSH.

PMCID: PMC494929  PMID: 7962642

Full text

PDF
777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol. 1991 Jul;78(3):325–329. doi: 10.1111/j.1365-2141.1991.tb04444.x. [DOI] [PubMed] [Google Scholar]
  2. Buccheri V., Shetty V., Yoshida N., Morilla R., Matutes E., Catovsky D. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry. Br J Haematol. 1992 Jan;80(1):62–68. doi: 10.1111/j.1365-2141.1992.tb06401.x. [DOI] [PubMed] [Google Scholar]
  3. Catovsky D., Matutes E., Buccheri V., Shetty V., Hanslip J., Yoshida N., Morilla R. A classification of acute leukaemia for the 1990s. Ann Hematol. 1991 Feb;62(1):16–21. doi: 10.1007/BF01714978. [DOI] [PubMed] [Google Scholar]
  4. Chan L. C., Pegram S. M., Greaves M. F. Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia. Lancet. 1985 Mar 2;1(8427):475–479. doi: 10.1016/s0140-6736(85)92085-9. [DOI] [PubMed] [Google Scholar]
  5. Greaves M. F., Chan L. C., Furley A. J., Watt S. M., Molgaard H. V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood. 1986 Jan;67(1):1–11. [PubMed] [Google Scholar]
  6. Greaves M. F., Janossy G., Peto J., Kay H. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol. 1981 Jun;48(2):179–197. [PubMed] [Google Scholar]
  7. Janossy G., Coustan-Smith E., Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia. 1989 Mar;3(3):170–181. [PubMed] [Google Scholar]
  8. Matutes E., Pombo de Oliveira M., Foroni L., Morilla R., Catovsky D. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia. Br J Haematol. 1988 Jun;69(2):205–211. doi: 10.1111/j.1365-2141.1988.tb07623.x. [DOI] [PubMed] [Google Scholar]
  9. Pombo de Oliveira M. S., Matutes E., Rani S., Morilla R., Catovsky D. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia. Acta Haematol. 1988;80(2):61–64. doi: 10.1159/000205603. [DOI] [PubMed] [Google Scholar]
  10. van Dongen J. J., Krissansen G. W., Wolvers-Tettero I. L., Comans-Bitter W. M., Adriaansen H. J., Hooijkaas H., van Wering E. R., Terhorst C. Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies. Blood. 1988 Mar;71(3):603–612. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES